Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-01-2020 | Nephrectomy | Original Article – Clinical Oncology

Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma

Authors: Feiya Yang, Qiang Zhou, Nianzeng Xing

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2020

Abstract

Purpose

Partial nephrectomy has been persuaded as a widely accepted surgical procedure for T1a (≤ 4 cm) renal tumors. However, when treating T1b (4–7 cm) renal cell carcinoma (RCC), the “optimal” method of surgery is still debatable. The aim of the research is to evaluate the long-term oncological and renal functional outcomes of laparoscopic radical nephrectomy (LRN) versus laparoscopic partial nephrectomy (LPN) for patients with T1b RCC.

Materials and methods

From March 1, 2003 to July 1, 2016, 331 patients were included in the current study. Patients presented with unilateral T1b RCC and underwent either LPN (n = 177) or LRN (n = 154). Relevant clinical data including follow-ups were acquired from patients.

Results

The operation time of the LPN group patients was longer than that of LRN group (94.3 min vs 88.3 min, p = 0.021) and LPN group patients required shorter stays in hospital (11.5 days vs. 13.4 days, p = 0.009). Contrast to LRN, level of eGFR was superior in LPN at the postoperative time of 1 day, 3 months, 6 months, 12 months and 24 months (all p < 0.001). Kaplan–Meier plots and log-rank tests showed that patients undergoing LPN had a much higher overall survival (OS) (p = 0.007), cancer-specific survival (CSS) (p = 0.006) and metastasis-free survival (MFS) (p = 0.008) than those receiving LRN. In comparison with the LRN group, multivariable Cox analysis indicated that patients of the LPN group had a 1.9-fold OS, 2.9-fold CSS and 2.3-fold MFS.

Conclusions

For patients with T1b RCC, our findings revealed that OS, CSS and MFS are superior in patients receiving LPN than those treated with LRN. With the benefit of preserving renal function of LPN, which leads a less incidence risk of other systematic diseases, LPN may be the preferred option when condition permits for cases involving T1b RCC.

Ahmedov V, Kizilay F, Cureklibatir I (2018) Prognostic significance of body mass index and other tumor and patient characteristics in non-metastatic renal cell carcinoma. Urol J 15:96–103. https://doi.org/10.22037/uj.v0i0.4067 CrossRefPubMed

Alimi Q et al (2018) Comparison of short-term functional, oncological, and perioperative outcomes between laparoscopic and robotic partial nephrectomy beyond the learning curve. J Laparoendosc Adv Surg 28:1047–1052. https://doi.org/10.1089/lap.2017.0724 CrossRef

Alyami FA, Rendon RA (2013) Laparoscopic partial nephrectomy for > 4 cm renal masses. Cancer Urol Assoc J 7:E281–286. https://doi.org/10.5489/cuaj.1003 CrossRef

Ani I, Finelli A, Alibhai SMH, Timilshina N, Fleshner N, Abouassaly R (2013) Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int 111:E300–E305. https://doi.org/10.1111/j.1464-410X.2012.11675.x CrossRefPubMed

Arora S et al (2018) Retroperitoneal vs transperitoneal robot-assisted partial nephrectomy: comparison in a multi-institutional setting. Urology 120:131–137. https://doi.org/10.1016/j.urology.2018.06.026 CrossRefPubMed

Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM (2012) Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach. BJU Int 109:1457–1462. https://doi.org/10.1111/j.1464-410x.2011.10597.x CrossRefPubMed

Benoit M et al (2018) Laparoscopic partial nephrectomy after selective embolization and robot-assisted partial nephrectomy: a comparison of short-term oncological and functional outcomes. Clin Genitourin Cancer 16:453–457. https://doi.org/10.1016/j.clgc.2018.07.005 CrossRefPubMed

Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A (2001) Obesity and renal cell cancer–a quantitative review. Br J Cancer 85:984–990. https://doi.org/10.1038/sj.bjc.6692040 CrossRefPubMedPubMedCentral

Campbell SC, Novick AC (2006) Expanding the indications for elective partial nephrectomy: is this advisable? Eur Urol 49:952–954. https://doi.org/10.1016/j.eururo.2006.03.005 CrossRefPubMed

Capitanio U et al (2015) Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol 67:683–689. https://doi.org/10.1016/j.eururo.2014.09.027 CrossRefPubMed

Chang KD et al (2018) Functional and oncological outcomes of open laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years’ follow-up. BJU Int 122:618–626. https://doi.org/10.1111/bju.14250 CrossRefPubMed

Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41. https://doi.org/10.1159/000180580 CrossRefPubMed

Deklaj T, Lifshitz DA, Shikanov SA, Katz MH, Zorn KC, Shalhav AL (2010) Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes. J Endourol 24:1603–1607. https://doi.org/10.1089/end.2009.0312 CrossRefPubMed

Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae CrossRefPubMedPubMedCentral

Ellison JS, Montgomery JS, Wolf JS, Hafez KS, Miller DC, Weizer AZ (2012) A matched comparison of perioperative outcomes of a single laparoscopic surgeon versus a multisurgeon robot-assisted cohort for partial nephrectomy. J Urol 188:45–50. https://doi.org/10.1016/j.juro.2012.02.2570 CrossRefPubMed

Fan XX et al (2013) Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: a systematic review and meta-analysis. BJU Int 111:611–621. https://doi.org/10.1111/j.1464-410X.2012.11598.x CrossRefPubMed

Favaretto RL et al (2013) Oncologic outcomes after laparoscopic partial nephrectomy: mid-term results. J Endourol 27:52–57. https://doi.org/10.1089/end.2012.0132 CrossRefPubMed

Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC (2002) Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13:287–293CrossRefPubMed

Garg M, Singh V, Sinha RJ, Sharma P (2014) Prospective randomized comparison of transperitoneal vs retroperitoneal laparoscopic simple nephrectomy. Urology 84:335–339. https://doi.org/10.1016/j.urology.2014.04.038 CrossRefPubMed

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305. https://doi.org/10.1056/nejmoa041031 CrossRefPubMed

Gu LY et al (2018) Laparoscopic vs robot-assisted partial nephrectomy for renal tumours of > 4 cm: a propensity score-based analysis. BJU Int 122:449–455. https://doi.org/10.1111/bju.14386 CrossRefPubMed

Iizuka J et al (2012) Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma. Int J Urol 19:980–986. https://doi.org/10.1111/j.1442-2042.2012.03085.x CrossRefPubMed

Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL (2004) Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 63:46–50. https://doi.org/10.1016/j.urology.2003.08.009 CrossRefPubMed

Kaushik D et al (2013) Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 64:600–606. https://doi.org/10.1016/j.eururo.2012.12.023 CrossRefPubMed

Kieran K, Montgomery JS, Daignault S, Roberts WW, Wolf JS Jr (2007) Comparison of intraoperative parameters and perioperative complications of retroperitoneal and transperitoneal approaches to laparoscopic partial nephrectomy: support for a retroperitoneal approach in selected patients. J Endourol 21:754–759. https://doi.org/10.1089/end.2007.0337 CrossRefPubMed

Kim SP et al (2012) Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 188:51–57. https://doi.org/10.1016/j.juro.2012.03.006 CrossRefPubMed

Kim JH, Park YH, Kim YJ, Kang SH, Byun SS, Kwak C, Hong SH (2015) Perioperative and long-term renal functional outcomes of robotic versus laparoscopic partial nephrectomy: a multicenter matched-pair comparison. World J Urol 33:1579–1584. https://doi.org/10.1007/s00345-015-1488-5 CrossRefPubMed

Kizilay F, Turna B, Apaydin E, Semerci B (2019) Comparison of long-term outcomes of laparoscopic and robot-assisted laparoscopic partial nephrectomy Kaohsiung. J Med Sci 35:238–243. https://doi.org/10.1002/kjm2.12038 CrossRef

Larcher A et al (2016) Elective nephron sparing surgery decreases other cause mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma. J Urol 196:1008–1013. https://doi.org/10.1016/j.juro.2016.04.093 CrossRefPubMed

Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H (2000) Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 75:1236–1242CrossRefPubMed

Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H (2004) Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171:1066–1070. https://doi.org/10.1097/01.ju.0000113274.40885.db CrossRefPubMed

Lesage K, Joniau S, Fransis K, Van Poppel H (2007) Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol 51:614–620. https://doi.org/10.1016/j.eururo.2006.10.040 CrossRefPubMed

Liss MA et al (2014) Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 14:101. https://doi.org/10.1186/1471-2490-14-101 CrossRefPubMedPubMedCentral

Ljungberg B et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924. https://doi.org/10.1016/j.eururo.2015.01.005 CrossRefPubMed

Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG (2007) Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 100:1235–1239. https://doi.org/10.1111/j.1464-410X.2007.07225.x CrossRefPubMed

Marszalek M et al (2011) Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approach. Urology 77:109–113. https://doi.org/10.1016/j.urology.2010.02.057 CrossRefPubMed

Minervini A, Mari A, Carini M, Porpiglia F (2016) Partial nephrectomy in clinical T1b renal tumors: multicenter comparative study of open, laparoscopic and robot-assisted approach (the record project) reply. Urology 89:52–53. https://doi.org/10.1016/j.urology.2015.08.051 CrossRefPubMed

Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R (2017) Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol 71:606–617. https://doi.org/10.1016/j.eururo.2016.08.060 CrossRefPubMed

Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264. https://doi.org/10.1016/j.urology.2005.08.057 CrossRefPubMed

Ng CS et al (2005) Transperitoneal versus retroperitoneal laparoscopic partial nephrectomy: patient selection and perioperative outcomes. J Urol 174:846–849. https://doi.org/10.1097/01.ju.0000169259.49754.02 CrossRefPubMed

Patard JJ et al (2007) Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 52:148–154. https://doi.org/10.1016/j.eururo.2007.01.039 CrossRefPubMed

Patel SG et al (2012) National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 187:816–821. https://doi.org/10.1016/j.juro.2011.10.173 CrossRefPubMed

Peyronnet B et al (2016) Comparison of 1800 robotic and open partial nephrectomies for renal tumors. Ann Surg Oncol 23:4277–4283. https://doi.org/10.1245/s10434-016-5411-0 CrossRefPubMed

Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373:1119–1132. https://doi.org/10.1016/S0140-6736(09)60229-4 CrossRefPubMed

Sammon J, Petros F, Sukumar S, Bhandari A, Kaul S, Menon M, Rogers C (2011) Barbed suture for renorrhaphy during robot-assisted partial nephrectomy. J Endourol 25:529–533. https://doi.org/10.1089/end.2010.0455 CrossRefPubMed

Tachibana H, Takagi T, Kondo T, Ishida H, Tanabe K (2018) Robot-assisted laparoscopic partial nephrectomy versus laparoscopic partial nephrectomy: a propensity score-matched comparative analysis of surgical outcomes and preserved renal parenchymal volume. Int J Urol 25:359–364. https://doi.org/10.1111/iju.13529 CrossRefPubMed

Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML (2009) Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 182:2601–2606. https://doi.org/10.1016/j.juro.2009.08.087 CrossRefPubMedPubMedCentral

Weight CJ et al (2010) Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol 58:293–298. https://doi.org/10.1016/j.eururo.2010.04.033 CrossRefPubMed

Wright JL, Porter JR (2005) Laparoscopic partial nephrectomy: comparison of transperitoneal and retroperitoneal approaches. J Urol 174:841–845. https://doi.org/10.1097/01.ju.0000169423.94253.46 CrossRefPubMed

Wu ZJ et al (2015) Propensity-score matched analysis comparing robot-assisted with laparoscopic partial nephrectomy. BJU Int 115:437–445. https://doi.org/10.1111/bju.12774 CrossRefPubMed

Yang FY, Zhou Q, Li XS, Xing NZ (2019) The methods and techniques of identifying renal pedicle vessels during retroperitoneal laparoscopic radical and partial nephrectomy. World J Surg Oncol. https://doi.org/10.1186/s12957-019-1580-1 CrossRefPubMedPubMedCentral

Yossepowitch O et al (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes J. Urology 179:2158–2163. https://doi.org/10.1016/j.juro.2008.01.100 CrossRef

Zini L et al (2009) Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer 115:1465–1471. https://doi.org/10.1002/cncr.24035 CrossRefPubMed

Title: Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma
Authors: Feiya Yang
Qiang Zhou
Nianzeng Xing
Publication date: 01-01-2020
Publisher: Springer Berlin Heidelberg
Keywords: Nephrectomy
Kidney Cancer
Kidney Cancer
Nephrectomy
Kidney Cancer
Nephrectomy
Published in: Journal of Cancer Research and Clinical Oncology / Issue 1/2020
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-019-03058-z

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women

18F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer

High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer

Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment

Evolving the pulmonary nodules diagnosis from classical approaches to deep learning-aided decision support: three decades’ development course and future prospect

Candidate lncRNA–miRNA–mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage